What causes pku in babies

What is PKU?

Phenylketonuria (PKU) is a rare, inherited metabolic disorder that affects how the body processes a specific building block of protein called an amino acid. Amino acids are used to build proteins, and we get them from the food we eat. One of these amino acids is phenylalanine. Normally, the body has an enzyme called phenylalanine hydroxylase (PAH) that converts phenylalanine into another amino acid, tyrosine. In individuals with PKU, this PAH enzyme is either missing or doesn't work properly. This means phenylalanine cannot be converted and builds up to toxic levels in the blood and tissues, especially the brain.

The Genetic Basis of PKU

PKU is an autosomal recessive genetic disorder. This means that a person must inherit two copies of the mutated gene – one from each parent – to have the condition. If a person inherits only one mutated gene, they are a carrier but usually do not show symptoms. The gene responsible for PKU is the PAH gene, located on chromosome 12. Mutations in this gene lead to the deficiency or inactivity of the PAH enzyme. The specific type and location of the mutation can influence the severity of the condition, ranging from mild to severe forms.

How PKU Affects the Body

When phenylalanine levels become too high, it can cross the blood-brain barrier and interfere with normal brain development and function. The exact mechanisms by which high phenylalanine levels cause brain damage are still being researched, but it is known to affect neurotransmitter synthesis, myelination (the insulation of nerve fibers), and overall brain structure. This damage can lead to a range of serious neurological problems. Without treatment, individuals with PKU typically develop severe intellectual disability, behavioral problems, seizures, and other neurological issues. High phenylalanine levels can also affect other parts of the body, leading to skin rashes (eczema) and a musty body odor due to the excretion of phenylacetic acid in urine and sweat.

Newborn Screening and Early Detection

Fortunately, PKU is one of the conditions included in routine newborn screening programs in many countries. A small blood sample is taken from the baby's heel a day or two after birth. This sample is tested for high levels of phenylalanine. If the screening test is positive, further diagnostic blood and urine tests are performed to confirm the diagnosis. Early detection is critical because the harmful effects of high phenylalanine levels are most significant during the early stages of brain development. With prompt diagnosis and treatment starting within the first few weeks of life, individuals with PKU can develop normally and lead healthy lives.

The Role of Diet in PKU Management

The cornerstone of PKU management is a lifelong, strict diet that is very low in phenylalanine. This means limiting the intake of high-protein foods such as meat, poultry, fish, eggs, dairy products, and legumes. Instead, individuals with PKU consume special medical formulas that provide the necessary protein and nutrients without the high levels of phenylalanine. They can eat small amounts of fruits, vegetables, and certain grains, carefully measured to keep phenylalanine intake within safe limits. Regular blood tests are performed to monitor phenylalanine levels and adjust the diet as needed. Adherence to the diet is crucial throughout childhood, adolescence, and adulthood, as elevated phenylalanine levels can still have negative cognitive and behavioral effects in older individuals.

Beyond Diet: Other Treatment Options

While diet is the primary treatment, other therapies are being developed and used. For some individuals with milder forms of PKU, a medication called sapropterin dihydrochloride (Kuvan) may be prescribed. Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), a cofactor that helps the PAH enzyme work more effectively. It can help lower phenylalanine levels in some patients, allowing for a slightly less restrictive diet. Gene therapy and enzyme replacement therapy are also areas of ongoing research, holding promise for future treatment options.

Living with PKU

With early diagnosis and consistent management, individuals with PKU can lead full and healthy lives. They can attend school, pursue careers, and have families. However, it requires careful attention to dietary needs, regular medical monitoring, and ongoing support. Understanding the genetic basis of PKU highlights the importance of genetic counseling for families with a history of the disorder and the continued success of newborn screening programs worldwide.